INFINIUM — Infinium Pharmachem Share Price
Last trade - 00:00- IN₹4.69bn
- IN₹4.88bn
- IN₹1.36bn
- 59
- 10
- 62
- 39
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.42 | ||
| Price to Tang. Book | 7.42 | ||
| Price to Free Cashflow | 122.49 | ||
| Price to Sales | 2.98 | ||
| EV to EBITDA | 29.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.29% | ||
| Return on Equity | 16.22% | ||
| Operating Margin | 8.78% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 388.42 | 705.31 | 991.19 | 1,142.25 | 1,356.39 | n/a | n/a | 36.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +191.74 | +124.1 | +112.74 | -13 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Infinium Pharmachem Limited is an India-based company. The Company is engaged in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. The Company's portfolio includes approximately 200+ Iodine Derivatives and seven Active Pharmaceutical Ingredients (APIs). It manufactures and supplies a range of Iodine based APIs, but on Order to Made basis only. It offers bulk actives, intermediates and services for custom synthesis. It also provides contract Research and manufacturing Services to the pharmaceutical and biotech companies for their diverse requirements of Iodine based APIs and intermediates to reduce their research time and project cost. It manufactures iodine derivatives for various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, agrochemical, electronics, Nylon production, and other industries for their range of industrial applications.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- November 21st, 2003
- Public Since
- April 17th, 2023
- No. of Shareholders
- 784
- No. of Employees
- 118
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 15,583,120
- Address
- 38 G I D C Sojitra Taluka Sojitra Dist, ANAND, 387240
- Web
- https://infiniumpharmachem.com/
- Phone
- +91 2692238849
- Auditors
- ASHOK RAJPARA & ASSOCIATES
Similar to INFINIUM
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 21:18 UTC, shares in Infinium Pharmachem are trading at IN₹300.95. This share price information is delayed by 15 minutes.
Shares in Infinium Pharmachem last closed at IN₹300.95 and the price had moved by +36.98% over the past 365 days. In terms of relative price strength the Infinium Pharmachem share price has outperformed the S&P BSE 100 Index by +29.04% over the past year.
There is no consensus recommendation for this security.
Find out moreInfinium Pharmachem does not currently pay a dividend.
Infinium Pharmachem does not currently pay a dividend.
Infinium Pharmachem does not currently pay a dividend.
To buy shares in Infinium Pharmachem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹300.95, shares in Infinium Pharmachem had a market capitalisation of IN₹4.69bn.
Here are the trading details for Infinium Pharmachem:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: INFINIUM
Based on an overall assessment of its quality, value and momentum Infinium Pharmachem is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Infinium Pharmachem. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -2.42%.
As of the last closing price of IN₹300.95, shares in Infinium Pharmachem were trading +12.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Infinium Pharmachem PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹300.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Infinium Pharmachem's directors